Tag: Oncology

Genetically Engineered Tattoo Shows Up if Person Has Cancer

As everyone knows, early diagnosis brings the best chance of fighting cancer. At ETH Zurich, a Swiss technical university, researchers genetically modified skin cells to produce a tattoo that makes itself visible only when the person wearing it has signs of cancer. The technology consists of a “synthetic gene network” that activates the (Read more...)

IBM Watson Artificial Intelligence System for Cancer Care: Interview with Elekta’s Andrew Wilson

Elekta, the big name in radiotherapy, radiosurgery, and oncology informatics that’s based in Sweden, recently partnered with IBM to offer the Watson for Oncology artificial intelligence (AI) platform along with its MOSAIQ Oncology Information System and other cancer care solutions. According to Richard Hausmann, the CEO of Elekta, it is &ldqu (Read more...)

New Highly Effective Camera for Spotting Dye Tagged Tumors

A collaboration between researchers at University of Illinois at Urbana-Champaign and Washington University in St. Louis has led to the development of a highly sensitive new camera for detecting fluorescent markers tagged on cancer tumors. It is smaller, more accurate, and relies on cheaper parts than existing devices used to detect the same near-i (Read more...)

ivWatch Detects IV Infiltrations and Extravasations: Interview with Gary Warren, President and CEO

ivWatch is a medical device manufacturer who we met with during CES 2018 in Las Vegas a couple months ago. They have developed of a non-invasive device that aims to establish a new standard of care for peripheral intravenous (IV) monitoring. The FDA-cleared ivWatch  continuously monitors a patient’s IV for the early detection of inf (Read more...)

Partial Wave Spectroscopy Spots Cells Turning to Cancer

Detecting cancer in the body usually happens when the disease is already well underway to being mortally dangerous. Although there’s a myriad of cancers and ways to detect them, diagnostic tests typically look for biomarkers produced by tumors. And the bigger the tumor, the more biomarkers it releases, so the bigger it is the easier [… (Read more...)

Machine Learning for Building Personalized Cancer Nanomedicines: Interview with Dr. Daniel Heller

Researchers at the Sloan Kettering Institute and the Weill Cornell Graduate School of Medical Sciences in New York have developed a machine learning approach to design personalized nanoparticle therapies for cancer. Personalized cancer therapies aim to provide a treatment that is tailored to the genetic makeup of a patient’s tumor. They can s (Read more...)